Andrea Allen

Summary

Affiliation: Mount Sinai School of Medicine
Country: USA

Publications

  1. ncbi request reprint An open-label trial of venlafaxine in body dysmorphic disorder
    Andrea Allen
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 13:138-44. 2008
  2. ncbi request reprint Body dysmorphic disorder
    A Allen
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Psychiatr Clin North Am 23:617-28. 2000
  3. ncbi request reprint Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review
    Bernardo Dell'Osso
    Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 67:600-10. 2006
  4. ncbi request reprint Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase
    Bernardo Dell'Osso
    Department of Psychiatry, Compulsive and Impulsive Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 69:452-6. 2008
  5. pmc Epidemiologic and clinical updates on impulse control disorders: a critical review
    Bernardo Dell'Osso
    Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
    Eur Arch Psychiatry Clin Neurosci 256:464-75. 2006
  6. ncbi request reprint Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Eric Hollander
    Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 64:546-50. 2003
  7. ncbi request reprint Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Eric Hollander
    Compulsive, Impulsive, and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am J Psychiatry 162:137-45. 2005
  8. ncbi request reprint Pharmacotherapy for obsessive-compulsive disorder
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Psychiatr Clin North Am 23:643-56. 2000
  9. ncbi request reprint A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Clin Psychiatry 62:199-203. 2001
  10. doi request reprint Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine
    S Pallanti
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
    J Psychopharmacol 24:847-53. 2010

Detail Information

Publications19

  1. ncbi request reprint An open-label trial of venlafaxine in body dysmorphic disorder
    Andrea Allen
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, USA
    CNS Spectr 13:138-44. 2008
    ..This open-label trial examines venlafaxine's efficacy in BDD and is the first known study of this serotonin-norepinephrine reuptake inhibitor in BDD...
  2. ncbi request reprint Body dysmorphic disorder
    A Allen
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Psychiatr Clin North Am 23:617-28. 2000
    ..Investigations in brain imaging and genetics are underway. Research in pharmacotherapy and CBT, individually and combined, is needed to refine, extend, and optimize treatment...
  3. ncbi request reprint Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review
    Bernardo Dell'Osso
    Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 67:600-10. 2006
    ....
  4. ncbi request reprint Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase
    Bernardo Dell'Osso
    Department of Psychiatry, Compulsive and Impulsive Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 69:452-6. 2008
    ..To assess the safety and efficacy of escitalopram in IC-IUD, we conducted a 10-week, open-label trial followed by a 9-week, double-blind, placebo-controlled discontinuation phase...
  5. pmc Epidemiologic and clinical updates on impulse control disorders: a critical review
    Bernardo Dell'Osso
    Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L Levy Place, Box 1230, New York, NY 10029, USA
    Eur Arch Psychiatry Clin Neurosci 256:464-75. 2006
    ..Particular attention is paid to the relationship between ICDs and obsessive-compulsive disorder (OCD). Finally, current pharmacological options for treating ICDs are presented and discussed...
  6. ncbi request reprint Venlafaxine in treatment-resistant obsessive-compulsive disorder
    Eric Hollander
    Department of Psychiatry, Compulsive, Impulsive, and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    J Clin Psychiatry 64:546-50. 2003
    ..Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) that might be effective in the treatment of OCD, even among those who have failed previous SSRI trials...
  7. ncbi request reprint Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?
    Eric Hollander
    Compulsive, Impulsive, and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029, USA
    Am J Psychiatry 162:137-45. 2005
    ..To the authors' knowledge, this is the first placebo-controlled treatment study in pathological gamblers with bipolar spectrum disorders; it compares sustained-release lithium carbonate to placebo...
  8. ncbi request reprint Pharmacotherapy for obsessive-compulsive disorder
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, New York, USA
    Psychiatr Clin North Am 23:643-56. 2000
    ..Augmentation and monotherapy have been explored with serotonergic enhancers, dopamine and 5-HT antagonists, enhancers of second-messenger systems, and GABAergic agents with varying efficacy...
  9. ncbi request reprint A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder
    E Hollander
    Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Clin Psychiatry 62:199-203. 2001
    ..Since anticonvulsant agents may be helpful in such symptomatology, we compared divalproex sodium with placebo in patients with borderline personality disorder...
  10. doi request reprint Noradrenergic function in pathological gambling: blunted growth hormone response to clonidine
    S Pallanti
    Department of Psychiatry, The Mount Sinai School of Medicine, New York, NY, USA
    J Psychopharmacol 24:847-53. 2010
    ..This peripheral noradrenergic dysfunction could be consistent with attenuated cortico-frontal noradrenergic function as shown in positron emission tomography (PET) studies of PG...
  11. ncbi request reprint Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions
    Bernardo Dell'Osso
    Department of Psychiatry, Compulsive, Impulsive and Anxiety Disorders Program, Mount Sinai School of Medicine, New York, NY 10029, USA
    CNS Spectr 10:966-79, 983. 2005
    ..Nevertheless, promising findings regarding efficacy, tolerability, and non-invasiveness and/or reversibility of these techniques have increased interest in investigating their use in treatment-resistant OCD...
  12. doi request reprint Serotonin function in pathological gambling: blunted growth hormone response to sumatriptan
    Stefano Pallanti
    Department of Psychiatry, The Mount Sinai School of Medicine, 1 Gustave Levy Place, New York, NY 10029, USA
    J Psychopharmacol 24:1802-9. 2010
    ..These results, together with those obtained in our previous serotoninergic challenge study, document the presence of a serotonergic dysfunction in pathological gamblers similar to that reported in alcoholics...
  13. ncbi request reprint Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine
    Eric Hollander
    Department of Psychiatry, Box 1230, Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY 10029 6574, USA
    J Clin Psychiatry 64:1113-21. 2003
    ..This study evaluated the acute safety and efficacy and long-term efficacy, safety, and impact on relapse prevention of paroxetine in obsessive-compulsive disorder...
  14. ncbi request reprint Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder
    Bernardo Dell'Osso
    Compulsive, Impulsive and Anxiety Disorders Program, Department of Psychiatry, Mount Sinai School of Medicine, Box 1230, New York, NY 10029, USA
    Expert Opin Pharmacother 6:2727-40. 2005
    ..This reflects the poor affinity of this compound for adrenergic, muscarinic, cholinergic or histaminergic receptors...
  15. ncbi request reprint A double-blind study of citalopram versus placebo in the treatment of compulsive sexual behaviors in gay and bisexual men
    Milton L Wainberg
    Columbia University, New York, NY, USA
    J Clin Psychiatry 67:1968-73. 2006
    ..The objective of this study was to conduct a preliminary double-blind, placebo-controlled evaluation of the efficacy, acceptability, and tolerability of citalopram in the treatment of CSB...
  16. ncbi request reprint Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders
    Sherie Novotny
    Department of Psychiatry, Seaver Autism Research Center at the Mount Sinai School of Medicine, One Gustave L Levy Place, New York, NY, 10029, USA
    Int J Neuropsychopharmacol 7:249-54. 2004
    ....
  17. doi request reprint Impulsive-compulsive buying disorder: clinical overview
    Bernardo Dell'Osso
    Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milano, Italy
    Aust N Z J Psychiatry 42:259-66. 2008
    ..The present review aims to provide a broad overview of the epidemiology, aetiology, phenomenology and treatment options of ICBD...
  18. ncbi request reprint Is compulsive buying a real disorder, and is it really compulsive?
    Eric Hollander
    Am J Psychiatry 163:1670-2. 2006